# clm_CC290D20ACB7

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: research_and_development  
value: 11,159,000,000 United States dollar  
valid_from: 2024-12-31  
valid_to: 2025-12-31  
published: 2025-02-12  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1D1D9926921B  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb research and development: 11,159,000,000 United States dollar", as of 2024-12-31 (until 2025-12-31). Claim clm_CC290D20ACB7, https://asof.is/claim/clm_CC290D20ACB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-12  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm (primary, SEC EDGAR 10-K FY2024, published 2025-02-12)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,299,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_CC290D20ACB7](/claim/clm_CC290D20ACB7.md) | [clm_5D4F25142B06](/claim/clm_5D4F25142B06.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.